141 related articles for article (PubMed ID: 7920692)
1. Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene.
Lin HJ; Han CY; Lin BK; Hardy S
Pharmacogenetics; 1994 Jun; 4(3):125-34. PubMed ID: 7920692
[TBL] [Abstract][Full Text] [Related]
2. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology.
Lin HJ; Han CY; Lin BK; Hardy S
Am J Hum Genet; 1993 Apr; 52(4):827-34. PubMed ID: 8460648
[TBL] [Abstract][Full Text] [Related]
3. Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol.
Rodriguez JW; Kirlin WG; Ferguson RJ; Doll MA; Gray K; Rustan TD; Lee ME; Kemp K; Urso P; Hein DW
Arch Toxicol; 1993; 67(7):445-52. PubMed ID: 7902079
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis.
Woolhouse NM; Qureshi MM; Bastaki SM; Patel M; Abdulrazzaq Y; Bayoumi RA
Pharmacogenetics; 1997 Feb; 7(1):73-82. PubMed ID: 9110365
[TBL] [Abstract][Full Text] [Related]
5. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans.
Bell DA; Taylor JA; Butler MA; Stephens EA; Wiest J; Brubaker LH; Kadlubar FF; Lucier GW
Carcinogenesis; 1993 Aug; 14(8):1689-92. PubMed ID: 8102597
[TBL] [Abstract][Full Text] [Related]
6. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA
Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
[TBL] [Abstract][Full Text] [Related]
7. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.
Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378
[TBL] [Abstract][Full Text] [Related]
8. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
Ferguson RJ; Doll MA; Rustan TD; Gray K; Hein DW
Drug Metab Dispos; 1994; 22(3):371-6. PubMed ID: 7915226
[TBL] [Abstract][Full Text] [Related]
9. N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men.
Hamasaki T; Inatomi H; Katoh T; Aono H; Ikuyama T; Muratani T; Matsumoto T
Int J Urol; 2003 Mar; 10(3):167-73. PubMed ID: 12622714
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients.
Agúndez JA; Ladero JM; Olivera M; Abildúa R; Román JM; Benítez J
Oncology; 1995; 52(1):7-11. PubMed ID: 7800347
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis.
Skretkowicz K; Skretkowicz J; Gawrońska-Szklarz B; Górnik W; Rychlik-Sych M; Sysa-Jedrzejowska A
Eur J Clin Pharmacol; 2005 Jan; 60(11):773-8. PubMed ID: 15565348
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
13. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of slow acetylation of drugs and carcinogens in humans.
Blum M; Demierre A; Grant DM; Heim M; Meyer UA
Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5237-41. PubMed ID: 1675794
[TBL] [Abstract][Full Text] [Related]
15. Strong association between N-acetyltransferase 2 genotype and PD in Hong Kong Chinese.
Chan DK; Lam MK; Wong R; Hung WT; Wilcken DE
Neurology; 2003 Mar; 60(6):1002-5. PubMed ID: 12654968
[TBL] [Abstract][Full Text] [Related]
16. Diverse point mutations in the human gene for polymorphic N-acetyltransferase.
Vatsis KP; Martell KJ; Weber WW
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6333-7. PubMed ID: 2068113
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer and mutations at the polymorphic NAT2 gene locus.
Martínez C; Agúndez JA; Olivera M; Martín R; Ladero JM; Benítez J
Pharmacogenetics; 1995 Aug; 5(4):207-14. PubMed ID: 8528267
[TBL] [Abstract][Full Text] [Related]
18. NAT2 gene polymorphisms in three indigenous groups in the Colombian Caribbean Coast region.
Arias I; Lecompte N; Visbal L; Curiel I; Hernández E; Garavito P; Silvera-Redondo C
Colomb Med (Cali); 2014; 45(4):148-53. PubMed ID: 25767302
[TBL] [Abstract][Full Text] [Related]
19. Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish population.
Mrozikiewicz PM; Cascorbi I; Brockmöller J; Roots I
Clin Pharmacol Ther; 1996 Apr; 59(4):376-82. PubMed ID: 8612380
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population.
Agúndez JA; Martínez C; Olivera M; Ledesma MC; Ladero JM; Benítez J
Clin Pharmacol Ther; 1994 Aug; 56(2):202-9. PubMed ID: 8062497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
